Results

Particle Detection in Model Tissue Phantoms and Biological Tissues (WP4)

Work Package 4

Detecting nanoparticles in tissues through correlative imaging

WP4 developed and evaluated workflows to identify, localise and compare inorganic nanoparticles in tissue phantoms and biological tissue models. By connecting optical, elemental and chemical imaging methods, the work examined how complementary views of the same sample can be combined into stronger spatial evidence.

One key lesson

A convincing image is not automatically a comparable measurement. The biological question, sample, method sequence, image registration and calibration strategy must be designed as one workflow.

One tissue region viewed through three complementary imaging approaches and combined into an aligned composite
WP4 at a glance
2public deliverables available on Zenodo
3core techniques in the controlled correlation
1internal interlaboratory comparison
1Academy replay with practical guidance

Our results

From controlled phantoms to evidence in biological matrices

Flagship result

Correlative localisation and distribution across increasing sample complexity

WP4 first compared complementary signals under controlled conditions, then examined what remained measurable in three-dimensional models, tissue sections and single-cell systems.

The strongest contribution is not one universal image or method. It is a practical evidence chain showing how sample complexity, signal mechanism, spatial resolution and method order shape what can be claimed.

Internal interlaboratory comparison (ILC)

Comparing complementary methods on shared reference samples

Within the WP4 internal ILC, participating laboratories compared results generated with complementary imaging and mass-spectrometry methods on common UCNP-containing phantom samples. Related studies then explored how these approaches performed in 3D tumour models, HfO₂-containing tissue sections and A549 cell systems, while keeping the limits of each method explicit.

  • UCNP calibrator phantoms
  • 3D tumour models
  • HfO₂ tissue sections
  • A549 cells
  • TPEF

    Optical mapping of fluorescent signals

  • ToF-SIMS

    Chemical and spatial surface information

  • LA-ICP-TOF-MS

    Quantitative elemental mapping

  • SEM-EDX

    Morphology and elemental identification

  • scICP-MS

    Single-cell mass quantification

  • Exploratory methods

    Including µCT, SAXS, Raman and fluorescence microscopy

Resources

Protocols and interlaboratory evidence

D7 consolidates protocols for biological sample preparation and nanoparticle measurements in cells and tissues. D8 documents the internal comparison of approaches for nanoparticle identification, localisation and quantification in tissue-phantom samples.

Deliverable D7Protocols

Preparing tissues and tissue phantoms, and measuring nanoparticle uptake and distribution

Published on ZenodoVersion 1 · CC BY 4.0(opens in a new tab)
What will you find in D7?
  • Preparation approaches for tissue phantoms and selected biological models.
  • SOPs covering uptake, quantification and spatial-distribution measurements.
  • Practical links between sample preparation, measurement method and intended claim.

Document type: SOP repository and reportVersion: 1Published: 30 April 2026DOI: 10.5281/zenodo.21537147Licence: CC BY 4.0

How can you use D7?
  • Start with controlled samples before moving to more complex tissues.
  • Match preparation and method order to the spatial or quantitative question.
  • Identify steps that require local adaptation and re-verification.
Deliverable D8Interlaboratory study

Comparing nanoparticle identification, localisation and quantification

Published on ZenodoVersion 1 · CC BY 4.0(opens in a new tab)
What will you find in D8?
  • The design and execution of the internal WP4 comparison.
  • Evidence from complementary techniques applied to controlled and selected biological systems.
  • Lessons on alignment, sensitivity, matrix effects and quantitative interpretation.

Document type: Internal ILC reportVersion: 1Published: 30 April 2026DOI: 10.5281/zenodo.21641447Licence: CC BY 4.0

How can you use D8?
  • Design comparisons around differences in measurand, scale, resolution and contrast mechanism.
  • Plan image alignment, calibration and data extraction before acquisition.
  • Use documented limitations to select fit-for-purpose methods without extending conclusions beyond tested systems.

Learn from the experts

How to plan correlative imaging before the first image is acquired

Plan from the evidence backwards

Correlative imaging starts with one question, not a collection of instruments. Four connected decisions determine whether different views can ultimately be compared.

  • Start hereWhat must correlative imaging reveal?
  • Define the claim

    Is the goal to detect, localise, quantify, identify chemistry or understand tissue context?

  • Select the model

    Choose controlled phantoms, 3D models, tissue sections or cells according to the evidence required.

  • Protect the shared sample

    Sequence methods so early measurements do not remove or alter information needed later.

  • Prepare the comparison

    Define landmarks, regions of interest, calibration, data formats and reporting before acquisition.

Academy 4 makes these decisions tangible by showing why one spot can generate several valid but different views — and why alignment remains one of the hardest practical steps.

METRINO Academy

One Spot, Many Eyes: Standardising Correlative Imaging

Presented by Dr Leonardo Mortati, INRiM.

  • Why techniques reveal different information from the same sample.
  • How acquisition order and image registration affect interpretation.
  • Why visual detection and quantitative measurement are not equivalent.
“Correlative imaging could be a powerful solution…”
Dr Leonardo Mortati, INRiM — Academy 4
84%of final-poll respondents said they would be likely to use a standardised correlative-imaging workflow if practical guidance were available.

What WP4 taught us

What the experiments showed — including where methods reached their limits

WP4 treated sample preparation, method order, registration and interpretation as one connected measurement problem. Its value lies both in the successful correlations and in the limitations observed.

  • 01

    Controlled phantoms separate method performance from biological complexity

    Known-content systems provide a necessary baseline before signals are interpreted in tissues or cellular models.

  • 02

    Biological matrices can obscure otherwise detectable signals

    Autofluorescence, surface roughness, background and sensitivity can change whether detection or quantification remains feasible.

  • 03

    Orthogonal techniques do not measure the same thing

    Optical, elemental and chemical approaches contribute different measurands and spatial scales; complementarity is not numerical equivalence.

  • 04

    Not every tested method belonged in the quantitative core

    Documenting when a method supports detection, localisation or quantification is part of trustworthy metrology, not a result to hide.

Operational limits are a result.

Exploratory work with additional tissues and techniques revealed cases where matrix overlap, nonspecific fluorescence, insufficient sensitivity or resolution prevented robust quantitative interpretation. Those boundaries help future users choose methods more realistically.

From results to community use

How to use the WP4 results in practice — and what should come next

Three practical ways to use the WP4 results

  • Plan the full workflow before collecting images.

    Use D7 and D8 to define the scientific claim, select the model, sequence the methods and prepare landmarks, regions of interest, calibration and reporting from the outset.

  • Interpret each view within its evidence limits.

    Use the tissue-phantom and biological-matrix findings, together with Academy 4, to distinguish detection, localisation, chemical identification and quantification — and to recognise when a method cannot support the intended claim.

  • Build the next comparisons and guidance.

    Use the internal ILC, SOPs and tissue-phantom experience to design comparable external studies and inform future protocol harmonisation, while keeping the validated scope and observed limitations visible.

Next
Next step beyond METRINO

METRINO’s internal ILC, SOPs and tissue-phantom experience are intended to support a future external study in collaboration with VAMAS TWA 40 . This follow-on work extends beyond METRINO and should not be presented as a completed or formally endorsed METRINO result.

WP4 scientific contact

Dr Leonardo Mortati

WP4 leader, INRiM (opens in a new tab)

Scientific contact for the WP4 work on tissue phantoms, correlative imaging, internal comparison and nanoparticle localisation in complex biological samples.

Built through collaboration

Organisations contributing models, materials, methods, measurements or scientific guidance to D7 and D8

The grid reflects organisations documented as contributors to D7 and D8.